Scinus Cell Expansion
Scinus Cell Expansion is a Netherlands‑based biotechnology company developing advanced bioreactor technologies that enable scalable, automated, and decentralized manufacturing of cell therapies. Their flagship Osilaris™ system supports high‑fold (>1000x) expansion of adherent and suspension cells, offering a cost‑efficient, GMP‑ready alternative to traditional 2D methods. Designed to maintain critical quality attributes through in‑line control of key process parameters, Scinus empowers organizations to produce clinical‑grade cells reliably and at scale. Their mission is to make cell therapies accessible for patients worldwide.